1 / 27

Ectopic pregnancy

Ectopic pregnancy. Dr.F Mostajeran MD. Ectopic pregnancy remains Leading cause life/hreatening F- Trimester (morbidity) Medical therapy method terexate as standard first line therop. Surgery Hemorrhage? Medical failures Neglected cases Medical contraindicated. Incidence E.P.

shania
Download Presentation

Ectopic pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ectopic pregnancy Dr.F Mostajeran MD

  2. Ectopic pregnancy remains Leading cause life/hreatening F- Trimester (morbidity) Medical therapy method terexate as standard first line therop. Surgery Hemorrhage? Medical failures Neglected cases Medical contraindicated

  3. Incidence E.P • Unprecedented sexual liberties. • ↑Ascertainment E.P • ↑ART • Leading cause maternal death U.S 5-6% all M. death

  4. Pathogenesis • Ability tube transport gametes embryos • Clinical picture site E.P • Most common site Tub 98-3% • Ampoule – isthmus – fimbrial cornual. • Rarely abdominal – ovarian – cervical.

  5. Proliferating trophoblast • Tubale wall • Growth may extend luminal mucosa. • Muscularis- serosa full thickness blood vessels • Distorts tube stretches serosa → pain bleeding takes phase. • 80% embryo degenerates. • 50% often clinically silent. • Tubal abortion self limited.

  6. Risk factors • Needs aggressive monitoring pregnancy immediately after first missed menses • High risk • Tubal surgery (21) • Risk factors • Tubal ligation • Tubal Epithelial damage. • Previous E.P (6-8) • I U D , Morning after pill • A R T

  7. Moderate risk • Infertility • P I D • Multiple sexual partners • Salpingitis • Low risk • Cigarette • Vaginal douching first intercourse <18

  8. Signs and symptoms • Many E.P never produce symptoms rather • Timely diagnosed and treated (H.R) • If diagnosis → delayed → classic triad. • Amenorrhea , irregular V.B , lower ab- pain. • Sudden sever ab pain 90-100% symptomatic patient. • Pain radiating shoulder. • Syncope shock → hemoperitaneum.( up to 20%)

  9. Most common signs ab EX • 90% tenderness ,rebound tenderness in 70%. • P.EX nonspecific. • 2⁄3 C-motion tenderness . • Adnexal mass 50%.

  10. Diagnosis • Diag as early as 4.5 WK. • Visualization is frequently not possible. • Traditional laparoscopic visualization rarely necessary. • Routine diagnostic Tests. • Serial 3HCG. • U.S • Progesterone levels. • U - curettage.

  11. Treatment for E.P • Medical management . • Methotrexate therapy. • Folic acid antagonist • DNA synthesis and cell multiplication. • Single dose 50 mg/m2 • Blunts HCG increment (7) • Drop progesterone, 17 × hydroxy progesterone prior to abortion • Hemodiamically stable. • E.P unruptured less 4cm • Eligible for methatrexate therapy.

  12. Multiple-dose: tailored weight-E.P responsiveness. • Comparing multiple-dose-laparoscopic salpingostomy. • Patent fallopian tubes. • Subsequent IU pregnancy. • Repeat E.P comparable . Single dose: • Resent metaanalysis 26 studies. • Based on clinical evidence presently available. • Routine use methotrexate single dose IM not as • Effective as multiple dose (tubal rupture↑)

  13. Indication for systemic M-dose methotrexate • No rupture • Tubal size ≤4cm • HCG ≤ 10,000 • Positive F.H heartbeat proceed with caution.

  14. Methotrexate by direct injection • Methotrexate E. gestational sac TVS. • Resolution within 2 weeks • Higher concentrations site of implantation. • Less systemic distribution drug • 75.1% successfully treated • Subsequent p–tubal patency (laparoscopic-systemic Mehta) • Subsequent – P, recurrent E.P

  15. Methotrexate failure • Pain is sever and persistent (>12h 4-12 3-7 after start therapy) • Falling HCT • Orthostatic hypotension.

  16. Side effects • High dose • Bone marrow supp • Hepatotoxicity • Stomatitis • Pulmonary fibrosis • Alopecia • Photosensitivity • Infrequent in E.P therapy

  17. Surgical Treatment • 1884 E.P laparotomy salpingectom. • 1953 salpingostomy • Manual fimbrial expression • Segmental resection.

  18. Ruptured E.P • Laparoscopy – laparotomy – salpingectomy. • Inpatients hypovolemic shock. • Surgery is choice.

  19. Stable E.P • If methotrexate contraindicated. • Laparoscopic salpigostomy first surgical choice. • Salpingectomy • Laparoscopy • Laparotomy

  20. Expectant management • E.P may resolve spontaneously • 67.2% E.P resolved without surgery (over treats) • Falling 3HCC under 1000 fallowed with conservative expectant management • With low initial and falling HCG

  21. Rare types of E.P • Abdominal pregnancy • 1⁄8000 birth prognosis poor • M.M 5.1⁄1000 7.7 higher than other E.P • (Higher due to delay in diagnosis)

  22. Primary - Secondary • Symptoms → normal for pregnancy to sever if time permits • Abdominal pain intra abdominal hemorrhage shock • Primary rare usually abort • Secondary (reimplantation → abortion ,rupture) • U.S choice empty uterus • If fetus near viability → hospitalization • Adequate blood, bowel preparation • Placenta removed unless major vessels, vital organ methotrexate

  23. Ovarian pregnancy • Most common form abdominal pregnancy • less than 3% of E.P • Clinical finding similar tubal E.P • ab-pain ,V.B Amenorrhea • 30% hemodynamic instability → rupture • Usually young multiparous cause • Treatment → systectomy, wedge resection or oophorectomy

  24. Cornual pregnancy or interstitial pregnancy • 4.7% E.P 2.2% M. mortality • Most frequent symptom menstrual aberration • Abdominal pain V.B, shock → rapture uterine(9-12nk) • Risk factor previous salpingectomy • Repeat U.S with Doppler flow studies → early diagnosis • Cornual resection lapa - resection systemic methatraxate local

  25. Cervical pregnancy 1⁄12000 Most common risk factor • D.C • Previous CS • IVF • Symptom most common V.B painless • C.EP usually diagnosis incidentally during routine U.S or at time surgery for abortion • Cervix enlarged- globular, distended it appears cyanotic hyperemic soft • Diagnosis – US, MRI , GSOC below C.OS, • Metha, U. Artery embolization, hysterectomy

  26. Heterotopic pregnancy • E.P + intrauterine pregnancy 1⁄6778 • Most causes diagnosed after sign symptoms develop admitted for emergency surgery • Lower abdominal pain serial 3HCG not helpful

More Related